Editas Medicine(us:EDIT)
1.25
-4.58%
Updated on 2024-12-23
Open:1.31
Close:1.25
High:1.34
Low:1.25
Pre Close:1.31
Volume:2.03M
Amount:2.59M
Turnover:2.46%
Shares:82.55M
MarketCap:103.19M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 264 | 56270203 | 68.26% | 46 | 64 | 106 |
| 2024-03-31 | 251 | 67871191 | 82.53% | 36 | 73 | 93 |
| 2023-12-31 | 253 | 58788292 | 71.90% | 38 | 51 | 108 |
| 2023-09-30 | 252 | 61513860 | 75.32% | 25 | 75 | 100 |
| 2023-06-30 | 265 | 62478625 | 76.55% | 42 | 74 | 86 |
| 2023-03-31 | 263 | 52056391 | 75.45% | 28 | 69 | 99 |
| 2022-12-31 | 294 | 54031034 | 78.48% | 42 | 63 | 118 |
| 2022-09-30 | 282 | 47912947 | 69.68% | 41 | 70 | 99 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Vanguard Group Inc | 8032604 | 9.74% | -522993 | -6.11% |
| 2024-06-30 | Blackrock Inc. | 7782517 | 9.44% | -50264 | -0.64% |
| 2024-06-30 | Deep Track Capital, Lp | 6000000 | 7.28% | 472710 | 8.55% |
| 2024-06-30 | State Street Corp | 4590913 | 5.57% | -4169238 | -47.59% |
| 2024-06-30 | Millennium Management Llc | 2459629 | 2.98% | 223012 | 9.97% |
| 2024-06-30 | Dimensional Fund Advisors Lp | 2345054 | 2.84% | -262711 | -10.07% |
| 2024-06-30 | Geode Capital Management, Llc | 1965822 | 2.38% | 21059 | 1.08% |
| 2024-06-30 | Pictet Asset Management Holding Sa | 1427277 | 1.73% | -834368 | -36.89% |
| 2024-06-30 | Goldman Sachs Group Inc | 1218687 | 1.48% | -182245 | -13.01% |
| 2024-06-30 | Woodline Partners Lp | 970491 | 1.18% | 75491 | 8.44% |
About
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
Address:11 Hurley Street
Website:http://www.editasmedicine.com
Market Movers